World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
45
Citations
8313
World Ranking
16352
National Ranking
74

Dionisios Vourloumis publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Dionisios Vourloumis sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 93 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Dionisios Vourloumis D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Dionisios Vourloumis sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 45 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Dionisios Vourloumis is affiliated with the Demokritos National Centre for Scientific Research in Greece. Their research spans fields including Medicine, Chemistry, and Biochemistry, Genetics and Molecular Biology, with particular focus on Molecular Biology, Organic Chemistry, Materials Chemistry, Oncology, and Infectious Diseases.

Their recent scholarly contributions include publications in several peer-reviewed journals:

  • Streamlined Symmetrical Total Synthesis of Disorazole B1 and Design, Synthesis, and Biological Investigation of Disorazole Analogues (2020), published in Journal of the American Chemical Society
  • Discovery of Selective Nanomolar Inhibitors for Insulin-Regulated Aminopeptidase Based on α-Hydroxy-β-amino Acid Derivatives of Bestatin (2022), published in Journal of Medicinal Chemistry
  • Design, Synthesis, and Biological Evaluation of Tubulysin Analogues, Linker-Drugs, and Antibody-Drug Conjugates, Insights into Structure-Activity Relationships, and Tubulysin-Tubulin Binding Derived from X-ray Crystallographic Analysis (2021), published in The Journal of Organic Chemistry
  • CCDC 2011802: Experimental Crystal Structure Determination (2020), published in The Cambridge Structural Database

Frequent co-authors collaborating with Dionisios Vourloumis include:

  • K. C. Nicolaou
  • Stefan Munneke
  • Christine Gu
  • Hetal Sarvaiaya
  • Joseph Sandoval

The scientist's research addresses topics such as:

  • Synthetic Organic Chemistry Methods
  • Chemical Synthesis and Analysis
  • Cancer therapeutics and mechanisms
  • Peptidase Inhibition and Analysis
  • Antifungal resistance and susceptibility
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Synthesis and biological activity

Publications by Dionisios Vourloumis have appeared in prominent venues, including:

  • Journal of the American Chemical Society
  • Journal of Medicinal Chemistry
  • The Journal of Organic Chemistry
  • The Cambridge Structural Database

Best Publications

  • The Art and Science of Total Synthesis at the Dawn of the Twenty-First Century

    K. C. Nicolaou;Dionisios Vourloumis;Nicolas Charles Winssinger;Phil S. Baran

  • Synthesis of epothilones A and B in solid and solution phase

    K. C. Nicolaou;Nicolas Charles Winssinger;Nicolas Charles Winssinger;J. Pastor;J. Pastor;S. Ninkovic;S. Ninkovic

  • Chemical Biology of Epothilones

    K. C. Nicolaou;Frank Roschangar;Dionisios Vourloumis

  • Total Syntheses of Epothilones A and B via a Macrolactonization-Based Strategy

    K. C. Nicolaou;S. Ninkovic;F. Sarabia;D. Vourloumis

  • Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, abd Cytotoxic Action against Taxol-Resistant Tumor Cells†

    K. C. Nicolaou;K. C. Nicolaou;Dionisios Vourloumis;Dionisios Vourloumis;Tianhu Li;Tianhu Li;Joaquin Pastor;Joaquin Pastor

  • Total Synthesis of Epothilone A: The Olefin Metathesis Approach

    Zhen Yang;Yun He;Dionisios Vourloumis;Hans Vallberg

  • The Olefin Metathesis Approach to Epothilone A and Its Analogues

    K. C. Nicolaou;Y. He;D. Vourloumis;H. Vallberg

  • Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes.

    Vasilis P. Androutsopoulos;Athanasios Papakyriakou;Dionisios Vourloumis;Aristidis M. Tsatsakis

  • The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site.

    Ernest Hamel;Dan L. Sackett;Dionisios Vourloumis;K. C. Nicolaou

  • SOLID AND SOLUTION PHASE SYNTHESIS AND BIOLOGICAL EVALUATION OF COMBINATORIAL SARCODICTYIN LIBRARIES

    K. C. Nicolaou;Nicolas Charles Winssinger;D. Vourloumis;T. Ohshima

  • Der Stand der Totalsynthese zu Beginn des 21. Jahrhunderts

    K. C. Nicolaou;Dionisios Vourloumis;Nicolas Winssinger;Phil S. Baran

  • An Approach to Epothilones Based on Olefin Metathesis

    K. C. Nicolaou;Yun He;Dionisios Vourloumis;Hans Vallberg

  • Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.

    Maria E. Katsarou;Eleni K. Efthimiadou;George Psomas;Alexandra Karaliota

  • Total synthesis of epothilone E and related side-chain modified analogues via a Stille coupling based strategy.

    K.C. Nicolaou;N.P. King;N.P. King;M.R.V. Finlay;M.R.V. Finlay;Y. He;Y. He

  • Monitoring Molecular Recognition of the Ribosomal Decoding Site

    Sarah Shandrick;Qiang Zhao;Qing Han;Benjamin K. Ayida

  • Total Synthesis of Eleutherobin

    K. C. Nicolaou;K. C. Nicolaou;Floris van Delft;Floris van Delft;Takashi Ohshima;Takashi Ohshima;Dionisios Vourloumis;Dionisios Vourloumis

  • Total Synthesis of Eleutherobin and Eleuthosides A and B

    K. C. Nicolaou;T. Ohshima;S. Hosokawa;F. L. Van Delft

  • Chemie und Biologie der Epothilone

    Kyriacos C. Nicolaou;Frank Roschangar;Dionisios Vourloumis

  • Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs

    Kyriacos C. Nicolaou;Dionisios Vourloumis;Sotirios Totokotsopoulos;Athanasios Papakyriakou

  • Total Synthesis of Epothilone E and Analogues with Modified Side Chains through the Stille Coupling Reaction

    K. C. Nicolaou;Yun He;Frank Roschangar;N. Paul King

  • Total Synthesis of Apoptolidin: Completion of the Synthesis and Analogue Synthesis and Evaluation

    K. C. Nicolaou;Yiwei Li;Kazuyuki Sugita;Holger Monenschein

Frequent Co-Authors

K. C. Nicolaou
K. C. Nicolaou Rice University
Yun He
Yun He Chongqing University
Nicolas Winssinger
Nicolas Winssinger University of Geneva
Takashi Ohshima
Takashi Ohshima Kyushu University
Sanghee Kim
Sanghee Kim Seoul National University
Zhen Yang
Zhen Yang Peking University
Thomas Hermann
Thomas Hermann University of California, San Diego
Jeffrey A. Pfefferkorn
Jeffrey A. Pfefferkorn Pfizer (United States)
Sofia Barluenga
Sofia Barluenga University of Geneva
Ernest Hamel
Ernest Hamel National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career pathways related to Chemistry often leads to diverse roles in science, healthcare, and legal settings. For individuals interested in transitioning into law enforcement or legal assistance, an online associates in criminal justice can provide foundational knowledge that complements a Chemistry background.

Similarly, pursuing paralegal studies can be a strategic move for those looking to merge scientific expertise with legal work. Understanding what types of paralegals make the most money can guide students to select specialized areas that offer the best financial rewards.

For Chemistry graduates attracted to the pharmaceutical industry, careers such as pharmaceutical sales rep are common. Learning about the typical pharma sales rep salary and career progression helps set realistic expectations and goals.

Alternatively, becoming a pharmacist remains a popular yet demanding career path. If you’re considering this route, it’s vital to understand is it hard to become a pharmacist to prepare for the academic and licensing challenges involved.

Best Scientists Citing Dionisios Vourloumis

Trending Scientists

Recently Published Articles